Panagora Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$297M Sell
322,677
-15,188
-4% -$15.4M 1.11% 12
2025
Q4
$363M Buy
337,865
+152,682
+82% +$146M 1.29% 11
2025
Q3
$141M Buy
185,183
+49,239
+36% +$36.6M 0.57% 36
2025
Q2
$106M Sell
135,944
-3,593
-3% -$2.79M 0.48% 46
2025
Q1
$115M Buy
139,537
+2,630
+2% +$2.19M 0.58% 35
2024
Q4
$106M Buy
136,907
+19,535
+17% +$16.2M 0.49% 49
2024
Q3
$104M Sell
117,372
-93,440
-44% -$84M 0.5% 47
2024
Q2
$191M Buy
210,812
+1,898
+0.9% +$1.52M 0.96% 13
2024
Q1
$163M Buy
208,914
+29,882
+17% +$21.3M 0.85% 16
2023
Q4
$104M Sell
179,032
-65,379
-27% -$38.2M 0.58% 43
2023
Q3
$131M Buy
244,411
+45,664
+23% +$23.5M 0.82% 21
2023
Q2
$93.2M Buy
198,747
+92,909
+88% +$39M 0.55% 37
2023
Q1
$36.3M Sell
105,838
-33,357
-24% -$11.2M 0.23% 108
2022
Q4
$50.9M Buy
139,195
+4,535
+3% +$1.61M 0.33% 77
2022
Q3
$43.5M Buy
134,660
+4,407
+3% +$1.4M 0.3% 87
2022
Q2
$42.2M Sell
130,253
-2,775
-2% -$833K 0.28% 88
2022
Q1
$38.1M Buy
133,028
+41,309
+45% +$10.6M 0.21% 118
2021
Q4
$25.3M Buy
91,719
+12,859
+16% +$3.26M 0.13% 159
2021
Q3
$18.2M Sell
78,860
-4,070
-5% -$1M 0.1% 202
2021
Q2
$19M Sell
82,930
-36,758
-31% -$7.38M 0.1% 200
2021
Q1
$22.4M Sell
119,688
-98,381
-45% -$19.2M 0.13% 166
2020
Q4
$36.8M Buy
218,069
+18,938
+10% +$2.83M 0.22% 106
2020
Q3
$29.5M Buy
199,131
+33,027
+20% +$5.11M 0.18% 118
2020
Q2
$27.3M Buy
166,104
+85,540
+106% +$13.1M 0.17% 116
2020
Q1
$11.2M Sell
80,564
-172,484
-68% -$23.7M 0.08% 216
2019
Q4
$33.3M Sell
253,048
-203,947
-45% -$23.6M 0.15% 148
2019
Q3
$51.1M Sell
456,995
-4,991
-1% -$556K 0.24% 106
2019
Q2
$51.2M Buy
461,986
+263,693
+133% +$31.1M 0.23% 107
2019
Q1
$25.7M Buy
198,293
+72,239
+57% +$8.78M 0.11% 179
2018
Q4
$14.6M Buy
126,054
+6,035
+5% +$674K 0.07% 250
2018
Q3
$12.9M Sell
120,019
-6,977
-5% -$698K 0.05% 310
2018
Q2
$10.8M Buy
126,996
+68,517
+117% +$5.63M 0.04% 334
2018
Q1
$4.53M Sell
58,479
-206,496
-78% -$16.6M 0.02% 571
2017
Q4
$22.4M Sell
264,975
-476,290
-64% -$40.5M 0.08% 235
2017
Q3
$63.4M Sell
741,265
-405,056
-35% -$33.2M 0.25% 99
2017
Q2
$94.3M Buy
1,146,321
+423,592
+59% +$34.6M 0.38% 59
2017
Q1
$60.8M Buy
722,729
+674,537
+1,400% +$54M 0.25% 91
2016
Q4
$3.54M Sell
48,192
-13,460
-22% -$1M 0.02% 666
2016
Q3
$4.95M Sell
61,652
-220,100
-78% -$17.6M 0.02% 553
2016
Q2
$22.2M Sell
281,752
-101,420
-26% -$7.64M 0.11% 192
2016
Q1
$27.6M Sell
383,172
-111,869
-23% -$8.46M 0.14% 159
2015
Q4
$41.7M Sell
495,041
-243,183
-33% -$20.2M 0.21% 117
2015
Q3
$61.8M Sell
738,224
-366,050
-33% -$30.9M 0.33% 71
2015
Q2
$92.2M Sell
1,104,274
-209,226
-16% -$15.9M 0.46% 46
2015
Q1
$95.4M Sell
1,313,500
-98,741
-7% -$7.03M 0.48% 47
2014
Q4
$97.4M Buy
1,412,241
+99,379
+8% +$6.71M 0.5% 44
2014
Q3
$85.1M Sell
1,312,862
-102,797
-7% -$6.51M 0.41% 64
2014
Q2
$88M Sell
1,415,659
-331,299
-19% -$19.8M 0.43% 62
2014
Q1
$103M Sell
1,746,958
-288,668
-14% -$16.1M 0.49% 45
2013
Q4
$104M Sell
2,035,626
-345,669
-15% -$17.3M 0.48% 47
2013
Q3
$120M Sell
2,381,295
-2,402,695
-50% -$126M 0.59% 37
2013
Q2
$235M Buy
+4,783,990
New +$260M 1.2% 11

Other funds holding LLY

Panagora Asset Management's LLY Position: Q1 2026 in Review

Panagora Asset Management reduced its Eli Lilly (LLY) stake by 4.5% in Q1 2026, selling an estimated $15.4M and leaving 322,677 shares worth $297M. The position accounts for 1.11% of the portfolio, ranked #12.

Panagora Asset Management first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $363M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Panagora Asset Management held 322,677 shares of Eli Lilly worth $297M as of Q1 2026.
  • Panagora Asset Management sold 15,188 Eli Lilly shares in Q1 2026, an estimated $15.4M.
  • Eli Lilly made up 1.11% of Panagora Asset Management's portfolio in Q1 2026, its #12 holding.
  • Panagora Asset Management first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • Panagora Asset Management's Eli Lilly position peaked at $363M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Panagora Asset Management's 13F filing for Q1 2026, filed 14 May 2026.